Literature DB >> 29956347

Echocardiographic predictors of neonatal illness severity in fetuses with critical left heart obstruction with intact or restrictive atrial septum.

Laura Gellis1,2, Monika Drogosz1, Minmin Lu1, Lynn A Sleeper1,2, Henry Cheng1,2, Catherine Allan1,2, Audrey C Marshall3, Wayne Tworetzky1,2, Kevin G Friedman1,2.   

Abstract

BACKGROUND: Neonates with critical left heart obstruction and intact atrial septum (IAS) or restrictive atrial septum (RAS) are at risk for hypoxia within hours of birth and remain a group at high risk for mortality.
METHODS: Prenatally diagnosed fetuses with critical left heart obstruction and IAS or RAS with follow-up from January 1, 2005, to February 14, 2017, were included. Primary outcome was a composite measure of severe neonatal illness (pH < 7.15, venous pH < 7.10, bicarbonate < 16 mmol/L, lactic acid > 5 mmol/L, or median oxygen saturation < 60% within 2 hours of birth).
RESULTS: Of 68 live born fetuses, 52 (76.5%) had hypoplastic left heart syndrome, 14 (20.5%) had critical aortic stenosis, and two (3%) had complex anatomy with mitral stenosis/atresia. There were 27 (39.7%) fetuses with IAS and 41 (60.3%) with RAS. Severe neonatal illness was present in 36 (52.9%). The strongest discriminators for severe neonatal illness were a pulmonary vein A:R VTI ≤ 2.7 (P < 0.001, AUC 0.93) and larger pulmonary vein diameter (P = 0.025, AUC 0.77). A:R VTI ≤ 2.7 predicted death or transplant (log-rank P = 0.03).
CONCLUSIONS: In neonates with hypoplastic left heart syndrome and IAS or RAS, A:R VTI ≤ 2.7 is predictive of severe neonatal instability. This threshold can help guide resource planning, delivery management, and improve fetal intervention criteria.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29956347     DOI: 10.1002/pd.5322

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  1 in total

1.  Commentary: Hypoplastic left heart syndrome with intact atrial septum: Planning for success.

Authors:  Harold M Burkhart; Arshid Mir; Randall M Schwartz
Journal:  JTCVS Open       Date:  2020-04-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.